Clinical Trial Update: Efficacy of Botulinum Toxin A in the Treatment of Bruxism-related Symptomatology [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating botulinum toxin A for bruxism-related symptoms has been terminated; the update references efficacy findings within this study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bruxism

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Bruxism | Phase 3 | Status: TERMINATED